{"id":97688,"date":"2023-09-02T19:46:54","date_gmt":"2023-09-02T19:46:54","guid":{"rendered":"https:\/\/dailytalks.org\/?p=97688"},"modified":"2023-09-02T19:46:54","modified_gmt":"2023-09-02T19:46:54","slug":"bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=97688","title":{"rendered":"Bayer says Parkinson&#8217;s stem cell therapy improves symptoms in initial trial"},"content":{"rendered":"<p>Bayer <a target=\"_blank\" rel=\"noopener\">https:\/\/www.reuters.com\/markets\/companies\/BAYGn.DE&#8221;<\/a> target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(BAYGn.DE)<\/a> said an experimental stem cell therapy developed by its U.S. subsidiary BlueRock had shown signs of easing Parkinson\u2019s disease symptoms in an early 12-patient tr\u2026<br \/><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-initial-trial-2023-08-28\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bayer https:\/\/www.reuters.com\/markets\/companies\/BAYGn.DE&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(BAYGn.DE) said an experimental stem cell therapy developed by its U.S. subsidiary<\/p>\n","protected":false},"author":1,"featured_media":97689,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-97688","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lse-mrkt"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial.jpg",1200,628,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-300x157.jpg",300,157,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-768x402.jpg",640,335,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-1024x536.jpg",640,335,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial.jpg",1200,628,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial.jpg",1200,628,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-1024x536.jpg",1024,536,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/97688-bayer-says-parkinsons-stem-cell-therapy-improves-symptoms-in-initial-trial-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=26\" rel=\"category\">London Market<\/a>","tag_info":"London Market","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/97688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=97688"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/97688\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/97689"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=97688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=97688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=97688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}